Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-23-000026
Filing Date
2023-10-27
Accepted
2023-10-27 12:39:53
Documents
5
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 6-K a6kcoverpagepressreleaseq3.htm 6-K 13544
2 EX-99.1 pressreleaseq32023english.htm EX-99.1 950785
3 GRAPHIC chart-565441fbd0eb45f2bb8a.jpg GRAPHIC 77797
4 GRAPHIC imagea.jpg GRAPHIC 4047
5 GRAPHIC ratingagenciesq323a.jpg GRAPHIC 94843
  Complete submission text file 0001121404-23-000026.txt   1209241
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 231354339
SIC: 2834 Pharmaceutical Preparations